ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      59,782.09
      0.92%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      07/24/20128:40AMPR Newswire (US)Aeterna Zentaris Requests Fast Track Designation from the FDA for AEZS-130 as Diagnostic Test for Adult Growth Hormone Defici...NASDAQ:AEZSAeterna Zentaris Inc
      07/24/20128:20AMMarketwiredDespite Navigating More Challenging Regulation Process Biotech Companies Thriving in 2012NASDAQ:AEZSAeterna Zentaris Inc
      07/13/20125:10PMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      07/10/201212:48PMMarketwiredSHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in AEterna Zentaris, Inc. of Class Act...NASDAQ:AEZSAeterna Zentaris Inc
      07/06/20129:31AMPR Newswire (Canada)Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The FirNASDAQ:AEZSAeterna Zentaris Inc
      07/05/20127:30AMPR Newswire (US)Aeterna Zentaris to Present at 7th Annual JMP Securities Healthcare Conference in New YorkNASDAQ:AEZSAeterna Zentaris Inc
      06/28/20127:30AMPR Newswire (US)Aeterna Zentaris: Partner Yakult Initiates Phase 1 Trial in Multiple Myeloma with Perifosine in JapanNASDAQ:AEZSAeterna Zentaris Inc
      06/26/201210:00AMPR Newswire (US)Investigation of Aeterna Zentaris, Inc. by Securities Lawyers at Goldfarb LLP Law Firm for Potential Shareholder ClaimNASDAQ:AEZSAeterna Zentaris Inc
      06/26/20127:30AMPR Newswire (US)Aeterna Zentaris: Final Phase 3 Results for AEZS-130 in Adult Growth Hormone Deficiency Presented at ENDO MeetingNASDAQ:AEZSAeterna Zentaris Inc
      06/25/20121:57PMGlobeNewswire Inc.Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in AEterna Zentaris Inc. to Inquire A...NASDAQ:AEZSAeterna Zentaris Inc
      06/21/20127:30AMPR Newswire (US)Aeterna Zentaris: Phase 1 Results Show Perifosine's Activity Against NeuroblastomaNASDAQ:AEZSAeterna Zentaris Inc
      06/19/20123:43PMBusiness WireThe Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in AEterna Zentaris, Inc. of Class Action...NASDAQ:AEZSAeterna Zentaris Inc
      06/19/20128:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:AEZSAeterna Zentaris Inc
      06/19/20127:30AMPR Newswire (US)Aeterna Zentaris Learns of Class Action Lawsuits Filed and Denies AllegationsNASDAQ:AEZSAeterna Zentaris Inc
      06/18/20123:19PMBusiness WireRobbins Umeda LLP Announces the Filing of a Class Action Suit Against AEterna Zentaris, Inc.NASDAQ:AEZSAeterna Zentaris Inc
      06/18/20127:30AMPR Newswire (US)Aeterna Zentaris: Phase 2 Data for Perifosine as Monotherapy for Renal Cell Carcinoma Published in June Issue of CancerNASDAQ:AEZSAeterna Zentaris Inc
      06/15/201210:00PMPR Newswire (US)Faruqi & Faruqi, LLP Files Class Action Lawsuit Against AEterna Zentaris Inc. - AEZSNASDAQ:AEZSAeterna Zentaris Inc
      06/14/20127:30AMPR Newswire (US)Aeterna Zentaris: Phase 3 Results for AEZS-130 in AGHD to be Presented at Upcoming ENDO MeetingNASDAQ:AEZSAeterna Zentaris Inc
      06/13/20128:30AMPR Newswire (US)Aeterna Zentaris: Poster on Phase 1 Results for Perifosine in Neuroblastoma to be Presented at Upcoming Neuroblastoma Researc...NASDAQ:AEZSAeterna Zentaris Inc
      06/12/20126:01AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:AEZSAeterna Zentaris Inc
      06/08/201210:41AMEdgar (US Regulatory)Amended Registration statement for securities of certain Canadian issuers under the Securities Act of 1933 (F-10/A)NASDAQ:AEZSAeterna Zentaris Inc
      06/05/20127:30AMPR Newswire (US)Aeterna Zentaris: Phase 1 Data for Perifosine in Multiple Myeloma Published in the British Journal of HaematologyNASDAQ:AEZSAeterna Zentaris Inc
      06/04/20127:30AMPR Newswire (US)Aeterna Zentaris: Phase 3 Data for Perifosine in Colorectal Cancer Presented at ASCO MeetingNASDAQ:AEZSAeterna Zentaris Inc
      06/01/20127:22PMBusiness WireRobbins Umeda LLP Announces an Investigation of Aeterna Zentaris Inc.NASDAQ:AEZSAeterna Zentaris Inc
      05/31/20127:30AMPR Newswire (US)Aeterna Zentaris: Article on Perifosine as Potential Novel Approach to the Treatment of Mesothelioma Published in Plos OneNASDAQ:AEZSAeterna Zentaris Inc
      05/25/20127:07PMPR Newswire (US)Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The F...NASDAQ:AEZSAeterna Zentaris Inc
      05/25/20125:26PMEdgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (F-X)NASDAQ:AEZSAeterna Zentaris Inc
      05/25/20125:08PMEdgar (US Regulatory)Registration statement for securities of certain Canadian issuers under the Securities Act of 1933 (F-10)NASDAQ:AEZSAeterna Zentaris Inc
      05/18/20128:20AMMarketwiredM&A Activity and a Growing Rate of FDA Approvals Contributing Factors to Biotech Industry's Success The Paragon Report Provid...NASDAQ:AEZSAeterna Zentaris Inc
      05/16/20124:15PMPR Newswire (US)Aeterna Zentaris Receives Notification from NASDAQ Relating to Minimum Bid PriceNASDAQ:AEZSAeterna Zentaris Inc
       Showing the most relevant articles for your search:NASDAQ:AEZS